Blockchain Registration Transaction Record

VERAXA Biotech Completes Business Combination, Begins Trading on Nasdaq

VERAXA Biotech (VRXA) completes business combination with Voyager Acquisition Corp., begins trading on Nasdaq. Learn about its BiTAC platform for cancer therapy.

VERAXA Biotech Completes Business Combination, Begins Trading on Nasdaq

This news matters because VERAXA Biotech's novel BiTAC platform has the potential to revolutionize cancer treatment by offering more targeted therapies with fewer side effects. The successful business combination and Nasdaq listing provide the company with the capital and visibility needed to advance its pipeline toward clinical trials, bringing hope to patients with difficult-to-treat cancers. Investors and the biotech community should watch for upcoming clinical data that could validate this innovative approach.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x959202ac6305e6b0c6b104fa1d8983d03274a2a0a0c02bba67094124f860ee85
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital Fingerprintwolfq2gI-3494f59d1889e0e280ada2bf55fed119